Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion type Assertion NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_head.
- NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion wasGeneratedBy ECO_0000203 NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_provenance.
- NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion wasDerivedFrom befree-20150227 NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_provenance.
- NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion SIO_000772 24185104 NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_provenance.
- NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion evidence source_evidence_literature NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_provenance.
- NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_assertion description "[14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881719.RAWsd7-RL69YbcSYAkrjDfU86-ZHN5KSD4LAnEE4rkDc8130_provenance.